US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 2.500
  • -0.070-2.72%
Close Aug 16 16:00 ET
  • 2.500
  • 0.0000.00%
Post 20:02 ET
75.44MMarket Cap-871P/E (TTM)

Relmada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.08%-13.26M
21.01%-13.04M
50.23%-51.66M
71.44%-10.25M
56.70%-11.63M
38.62%-13.27M
15.05%-16.51M
-12.98%-103.8M
4.72%-35.88M
-28.43%-26.86M
Net income from continuing operations
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
7.48%-39.42M
Operating gains losses
---133.11K
-107.97%-53.13K
594.15%4.06M
9,932.59%3.35M
-90.79%51.71K
--0
4,338.21%666.71K
-7.94%585.52K
-72.82%33.35K
66.69%561.65K
Other non cash items
----
----
----
----
----
----
----
---6.35M
----
----
Change In working capital
-1,288.33%-2.62M
165.65%599.76K
-70.92%3.08M
252.02%5.43M
54.69%-1.65M
-98.03%220.53K
-113.83%-913.58K
234.69%10.59M
69.64%-3.57M
-214.57%-3.65M
-Change in receivables
--0
--0
220.27%512.43K
--0
--0
--0
2,349.13%512.43K
-636.21%-426.06K
-2,600.89%-512.43K
1,387.07%298.43K
-Change in prepaid assets
153.11%204.31K
-54.24%432.72K
-60.85%2.84M
250.29%1.65M
14.25%627.38K
-124.45%-384.68K
-84.84%945.61K
169.79%7.26M
87.19%-1.1M
147.07%549.15K
-Change in payables and accrued expense
-566.78%-2.82M
107.04%167.03K
-107.29%-274.08K
292.81%3.77M
49.28%-2.28M
-93.86%605.21K
-780.42%-2.37M
52.99%3.76M
38.59%-1.96M
-203.81%-4.5M
Cash from discontinued investing activities
Operating cash flow
0.08%-13.26M
21.01%-13.04M
50.23%-51.66M
71.44%-10.25M
56.70%-11.63M
38.62%-13.27M
15.05%-16.51M
-12.98%-103.8M
4.72%-35.88M
-28.43%-26.86M
Investing cash flow
Cash flow from continuing investing activities
1,316.79%14.01M
-74.86%10.06M
155.67%50.45M
567.62%7.74M
-87.77%3.86M
-719.62%-1.15M
498.93%40M
136.46%19.73M
98.18%-1.66M
14.71%31.56M
Net investment purchase and sale
1,316.79%14.01M
-74.86%10.06M
155.67%50.45M
567.62%7.74M
-87.77%3.86M
-719.62%-1.15M
498.93%40M
136.46%19.73M
98.18%-1.66M
14.71%31.56M
Cash from discontinued investing activities
Investing cash flow
1,316.79%14.01M
-74.86%10.06M
155.67%50.45M
567.62%7.74M
-87.77%3.86M
-719.62%-1.15M
498.93%40M
136.46%19.73M
98.18%-1.66M
14.71%31.56M
Financing cash flow
Cash flow from continuing financing activities
0
221.75K
-100.22%-98.46K
-124.02%-98.46K
0
0
0
-76.05%45.02M
-99.75%409.88K
207.36%569.09K
Net common stock issuance
----
----
--0
--0
--0
----
----
-76.94%42.73M
-100.44%-703.72K
6,838.67%703.72K
Proceeds from stock option exercised by employees
----
--246.75K
--0
--0
----
----
--0
-25.11%1.97M
44.78%739.97K
-148.35%-84.63K
Net other financing activities
--0
---25K
-130.42%-98.46K
----
----
----
----
--323.63K
--373.63K
----
Cash from discontinued financing activities
Financing cash flow
--0
--221.75K
-100.22%-98.46K
-124.02%-98.46K
--0
--0
--0
-76.05%45.02M
-99.75%409.88K
207.36%569.09K
Net cash flow
Beginning cash position
-95.38%1.34M
-24.17%4.09M
-87.86%5.4M
-84.25%6.7M
-61.17%14.47M
-35.70%28.89M
-87.86%5.4M
1,681.02%44.44M
271.41%42.52M
697.99%37.26M
Current changes in cash
105.21%751.24K
-111.73%-2.76M
96.66%-1.3M
92.98%-2.61M
-247.63%-7.77M
-87.98%-14.43M
4,686.45%23.5M
-193.09%-39.05M
-212.53%-37.13M
-22.37%5.26M
End cash Position
-85.58%2.09M
-95.38%1.34M
-24.17%4.09M
-24.17%4.09M
-84.25%6.7M
-61.17%14.47M
-35.70%28.89M
-87.86%5.4M
-87.86%5.4M
271.41%42.52M
Free cash flow
0.08%-13.26M
21.01%-13.04M
50.23%-51.66M
71.44%-10.25M
56.70%-11.63M
38.62%-13.27M
15.05%-16.51M
-12.98%-103.8M
4.72%-35.88M
-28.43%-26.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.08%-13.26M21.01%-13.04M50.23%-51.66M71.44%-10.25M56.70%-11.63M38.62%-13.27M15.05%-16.51M-12.98%-103.8M4.72%-35.88M-28.43%-26.86M
Net income from continuing operations 29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M7.48%-39.42M
Operating gains losses ---133.11K-107.97%-53.13K594.15%4.06M9,932.59%3.35M-90.79%51.71K--04,338.21%666.71K-7.94%585.52K-72.82%33.35K66.69%561.65K
Other non cash items -------------------------------6.35M--------
Change In working capital -1,288.33%-2.62M165.65%599.76K-70.92%3.08M252.02%5.43M54.69%-1.65M-98.03%220.53K-113.83%-913.58K234.69%10.59M69.64%-3.57M-214.57%-3.65M
-Change in receivables --0--0220.27%512.43K--0--0--02,349.13%512.43K-636.21%-426.06K-2,600.89%-512.43K1,387.07%298.43K
-Change in prepaid assets 153.11%204.31K-54.24%432.72K-60.85%2.84M250.29%1.65M14.25%627.38K-124.45%-384.68K-84.84%945.61K169.79%7.26M87.19%-1.1M147.07%549.15K
-Change in payables and accrued expense -566.78%-2.82M107.04%167.03K-107.29%-274.08K292.81%3.77M49.28%-2.28M-93.86%605.21K-780.42%-2.37M52.99%3.76M38.59%-1.96M-203.81%-4.5M
Cash from discontinued investing activities
Operating cash flow 0.08%-13.26M21.01%-13.04M50.23%-51.66M71.44%-10.25M56.70%-11.63M38.62%-13.27M15.05%-16.51M-12.98%-103.8M4.72%-35.88M-28.43%-26.86M
Investing cash flow
Cash flow from continuing investing activities 1,316.79%14.01M-74.86%10.06M155.67%50.45M567.62%7.74M-87.77%3.86M-719.62%-1.15M498.93%40M136.46%19.73M98.18%-1.66M14.71%31.56M
Net investment purchase and sale 1,316.79%14.01M-74.86%10.06M155.67%50.45M567.62%7.74M-87.77%3.86M-719.62%-1.15M498.93%40M136.46%19.73M98.18%-1.66M14.71%31.56M
Cash from discontinued investing activities
Investing cash flow 1,316.79%14.01M-74.86%10.06M155.67%50.45M567.62%7.74M-87.77%3.86M-719.62%-1.15M498.93%40M136.46%19.73M98.18%-1.66M14.71%31.56M
Financing cash flow
Cash flow from continuing financing activities 0221.75K-100.22%-98.46K-124.02%-98.46K000-76.05%45.02M-99.75%409.88K207.36%569.09K
Net common stock issuance ----------0--0--0---------76.94%42.73M-100.44%-703.72K6,838.67%703.72K
Proceeds from stock option exercised by employees ------246.75K--0--0----------0-25.11%1.97M44.78%739.97K-148.35%-84.63K
Net other financing activities --0---25K-130.42%-98.46K------------------323.63K--373.63K----
Cash from discontinued financing activities
Financing cash flow --0--221.75K-100.22%-98.46K-124.02%-98.46K--0--0--0-76.05%45.02M-99.75%409.88K207.36%569.09K
Net cash flow
Beginning cash position -95.38%1.34M-24.17%4.09M-87.86%5.4M-84.25%6.7M-61.17%14.47M-35.70%28.89M-87.86%5.4M1,681.02%44.44M271.41%42.52M697.99%37.26M
Current changes in cash 105.21%751.24K-111.73%-2.76M96.66%-1.3M92.98%-2.61M-247.63%-7.77M-87.98%-14.43M4,686.45%23.5M-193.09%-39.05M-212.53%-37.13M-22.37%5.26M
End cash Position -85.58%2.09M-95.38%1.34M-24.17%4.09M-24.17%4.09M-84.25%6.7M-61.17%14.47M-35.70%28.89M-87.86%5.4M-87.86%5.4M271.41%42.52M
Free cash flow 0.08%-13.26M21.01%-13.04M50.23%-51.66M71.44%-10.25M56.70%-11.63M38.62%-13.27M15.05%-16.51M-12.98%-103.8M4.72%-35.88M-28.43%-26.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg